1.
177RO Regulatory approval delays for pembrolizumab and trastuzumab deruxtecan across the Asia-Pacific region
Date of Publication: 01 Jul 2026
2.
Leveraging Real-World Evidence to Drive Advances in Oncology Care in the Asia-Pacific Region: Recommendations From the Asia-Pacific Oncology Drug Development Consortium Working Group
Date of Publication: 14 Oct 2026
3.
88O Improving access to clinical trials and novel therapeutics for advanced solid tumours in the Asia-Pacific Region: Insights from the ASTER study
Date of Publication: 01 Aug 2025
4.
Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group
Date of Publication: 01 Aug 2023